Leading Companies - Transcatheter Aortic Valve Implantation Industry

Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical technique used to replace a diseased aortic valve with an artificial valve. The increasing prevalence of aortic stenosis, a growing aging population, and the rising demand for minimally invasive surgical procedures are key drivers of the TAVI market. Additionally, advancements in technology, such as the development of novel implantable devices, and favorable reimbursement policies are expected to boost market growth. However, the high cost of the procedure, the lack of skilled healthcare professionals, and the risks associated with the surgery, such as vascular complications and stroke, may hinder market growth. The Transcatheter Aortic Valve Implantation Market is expected to witness significant growth in North America and Europe due to the high prevalence of cardiovascular diseases in these regions.

Top Companies in the Transcatheter Aortic Valve Implantation Industry:

Edwards Lifesciences:

This American medical technology company was founded in 1958 and is headquartered in Irvine, California. Edwards Lifesciences focuses on developing innovative medical technologies to help patients with structural heart disease and critical care monitoring. The company operates in over 100 countries worldwide and has manufacturing facilities in the United States, Europe, and Asia. In October 2022, Edwards Lifesciences announced the commercial launch of its next-generation self-expanding transcatheter aortic valve, the EVOLUT PRO+ TAVR system.

Boston Scientific Corporation:

This American medical device company was founded in 1979 and is headquartered in Marlborough, Massachusetts. Boston Scientific develops and manufactures a wide range of medical devices, including those for the cardiovascular, urology, and neurology specialties. The company operates in over 100 countries worldwide and has manufacturing facilities in the United States, Europe, and Asia. In January 2023, Boston Scientific announced the completion of its acquisition of Symetis SA, a company that develops and produces minimally invasive heart valve replacement devices.

Jenavalve Technology, Inc.:

This German medical technology company was founded in 2006 and is headquartered in Munich, Germany. Jenavalve Technology develops and produces innovative transcatheter heart valves for the treatment of aortic valve stenosis. The company operates in Europe, the Middle East, and Asia. In October 2022, Jenavalve Technology announced the successful completion of its first-in-human study of the JenaValve Pericardial TAVR System.

HLT, Inc.

Founded in 2015 and headquartered in Maple Grove, Minnesota, HLT, Inc. is a medical technology company that develops and manufactures transcatheter heart valve technologies for the treatment of structural heart diseases. The company operates in several countries, including the United States and Germany. In March 2022, HLT announced the enrollment of its first patient in the ELEVATE clinical trial, which is designed to evaluate the safety and efficacy of the company's Meridian transcatheter valve system.

Meril Life Sciences Pvt. Ltd.

Founded in 2006 and headquartered in Gujarat, India, Meril Life Sciences Pvt. Ltd. is a medical technology company that specializes in the development and manufacturing of medical devices for various medical specialties, including cardiovascular, orthopedics, and neurology. The company operates in several countries, including India, the United States, and the United Kingdom. In November 2021, Meril Life Sciences announced the launch of its MYVAL transcatheter aortic valve replacement system.

Medtronic Plc.

Founded in 1949 and headquartered in Dublin, Ireland, Medtronic Plc. is a global medical technology company that develops and manufactures innovative medical devices and therapies for the treatment of various diseases, including cardiovascular, diabetes, and neurological disorders. The company operates in more than 150 countries worldwide, including the United States, China, and Germany. In November 2021, Medtronic announced the first patient enrollment in its clinical trial evaluating the use of its Intrepid transcatheter mitral valve replacement system.

St. Jude Medical, Inc.

Founded in 1976 and headquartered in Saint Paul, Minnesota, St. Jude Medical, Inc. is a medical technology company that develops and manufactures medical devices for the treatment of various diseases, including cardiovascular, neurological, and chronic pain. The company operates in several countries, including the United States, China, and Germany. In April 2022, St. Jude Medical announced the launch of its new Masters HP 15mm valve for transcatheter aortic valve replacement.

Definition-

Transcatheter aortic valve implantation (TAVI), also known as transcatheter aortic valve replacement (TAVR), is a minimally invasive surgical procedure to replace a damaged aortic valve with an artificial valve through a catheter inserted in the patient's artery.